Skip to content
  • My Accountmy account
  • Search
FLCCC | Front Line COVID-19 Critical Care Alliance
  • Treatment
    Protocols

    • Protocols

      Read about strategies to prevent and treat conditions like COVID-19, insulin resistance, RSV, long COVID, and more.

      Learn More
      Prevention

      Boost your immune system, clear your body of spike protein, and learn the benefits of intermittent fasting.

      • EAT WELL
      • I-PREVENT Vaccine Injury
      • See all Prevention Protocols
      Treatment

      At-home and hospital treatment plans for COVID, insulin resistance, sepsis, RSV and flu.

      • I-CARE Early At Home Treatment
      • I-CARE RSV and Flu Treatment
      • See all Treatment Protocols
      Recovery

      Approaches to managing symptoms from long COVID and long Vax.

      • I-RECOVER Post Vaccine Treatment
      • I-RECOVER Long Covid
      • See all Recovery Protocols
  • Medical
    Evidence
    • Reviews & Monographs

      In-depth academic pieces presenting original research, analysis, and evidence on complex conditions.

      Cancer Care
    • Studies

      A comprehensive listing of all research, studies, authors and sources cited in each FLCCC prevention and treatment protocol for COVID-19

      Learn More
    • Lectures

      Watch FLCCC doctors speak at international medical conferences, professional seminars and symposiums.

      Learn More
    • Senate Testimony

      Watch Dr. Pierre Kory testify before the U.S. Senate regarding FLCCC protocols to treat COVID-19.

      Learn More
  • COVID
    Resources

    • Wondering where to begin?

      Let us help you find what you’re looking for. We know COVID-19 can be overwhelming; click below to learn more about the resources available to you on this website.

      get started
      Patient Resources
      • Find a Provider
      • Find a Pharmacy
      • Tools & Guides
      • Testimonials
      • Hospital Guide
      Practitioner Resources
      • Efficacy of Ivermectin
      • Informed Consent
      • Nurses for FLCCC
      • Join the Alliance
      • Education on Demand
  • Education &
    Events

    • About the education portal

      FLCCC’s goal is to educate healthcare providers and empower patients with the tools and resources they need to take control of their own health.

      Events

      Our twice-yearly conferences bring top experts from a variety of fields together to learn, share, and network with each other.

      • Learn More
      Education on Demand

      Stream video lectures, download slide presentations, and get exclusive access to key facts, data, and references from FLCCC educational programs.

      • My Content
      • Explore Courses
  • News &
    Webinars
    • Latest Updates

      Stay up-to-date with the latest news from our fast-moving field.

      View
    • Blog

      Subscribe to our blog to read our weekly news capsule and be the first to receive the latest announcements from FLCCC.

      Read Now
    • Weekly Webinars

      Sign up for our webinars, every Wednesday at 7pm ET, offering the latest information on therapeutics and treatments and answering audience questions.

      Learn More
    • FLCCC in the News

      Read media coverage of FLCCC from around the world.

      View
  • About
    FLCCC

    • About the FLCCC

      Learn about the history of FLCCC, our mission and vision, and how you can get involved.

      learn more
      • Our Physicians
      • Our Partners
      • Advocacy
      • FAQ
      • Terms and Conditions
      • Impact Reports
      • Annual Reports
      • Support Us
      • Shop our Store
      • Connect with Us
  • Donate
  • Treatment Protocols
  • Find a Provider
  • Find a Pharmacy
  • Medical Evidence
    • Cancer Care
    • Studies
    • Lectures
    • Senate Testimony
  • COVID Resources
    • Get Started
    • Tools & Guides
    • Ivermectin
    • Hospital Guide
    • Nurses for FLCCC
    • Join The Alliance
  • Education & Events
    • Educational Conference
    • Education on Demand
    • My Content
  • News & Webinars
    • Latest Updates
    • FLCCC Blog
    • Weekly Webinars
    • FLCCC in the News
  • About The FLCCC
  • FAQ
  • Connect with Us
  • Donate
  • Cart
FLCCC | Front Line COVID-19 Critical Care Alliance
  • Treatment Protocols
  • Find a Provider
  • Find a Pharmacy
  • Medical Evidence
    • Cancer Care
    • Studies
    • Lectures
    • Senate Testimony
  • COVID Resources
    • Get Started
    • Tools & Guides
    • Ivermectin
    • Hospital Guide
    • Nurses for FLCCC
    • Join The Alliance
  • Education & Events
    • Educational Conference
    • Education on Demand
    • My Content
  • News & Webinars
    • Latest Updates
    • FLCCC Blog
    • Weekly Webinars
    • FLCCC in the News
  • About The FLCCC
  • FAQ
  • Connect with Us
  • Donate
  • Cart
Donate

References

Categories

I-CARE Early Covid (187) I-CARE Flu and RSV (36) I-PREVENT (153) I-RECOVER Long Covid (111) I-RECOVER Post-Vaccine (320) MATH+ (198)

Tags

ACE2 protein (10) acute respiratory distress syndrome (14) Alopecia (7) Anti-inflammatory (9) Antidepressants (9) Ascorbic Acid (12) autoantibodies (10) autophagy (24) Calcifediol (6) Cancer (9) Corticosteroids (9) COVID-19 (270) COVID-19 Vaccines (8) Curcumin (8) Cytokines (12) Depression (10) Famotidine (14) flavonoids (5) Glucocorticoids (7) Hydroxychloroquine (12) Hyperbaric Oxygen Therapy (9) Inflammation (14) ivermectin (47) long COVID (21) Mast Cells (8) Melatonin (20) Methylprednisolone (7) molnupiravir (5) N-Acetylcysteine (6) Non-Invasive Brain Stimulation (8) Omicron (7) Oxytocin (8) Pneumonia (8) quercetin (15) SARS-CoV-2 (72) SARS-CoV-2 mRNA Vaccines (7) Sepsis (18) spermidine (11) Spike Protein (10) Thiamine (7) Thrombosis (9) Tinnitus (12) Vitamin C (28) Vitamin D (10) Zinc (12)
  • Reference: Outcomes of laboratory-confirmed SARS-CoV-2 infection during resurgence driven by Omicron lineages BA.4 and BA.5 compared with previous waves in the Western Cape Province, South Africa.

    Published On: November 24, 2022

    Authors: Davies MA, Morden E, Rosseau P, Arendse J, Bam JL, Cloete K et al. PMID: 36436752 PMCID: PMC9686046 DOI: 10.1016/j.ijid.2022.11.024 Abstract Objectives: We aimed to compare the clinical severity of Omicron BA.4/BA.5 infection with BA.1 and earlier variant infections among laboratory-confirmed SARS-CoV-2 cases in the Western Cape, South Africa, using timing of infection to [...]

    Categories: I-CARE Early Covid

    Tags:

  • Reference: Clinical severity of SARS-CoV-2 Omicron BA.4 andBA.5 lineages in South Africa.

    Published On: October 4, 2022

    Authors: Wolter N, Jassat W, Walaza S, Welch R, Moultrie H, Groome M PMID: 36195617 PMCID: PMC9531215 DOI: 10.1038/s41467-022-33614-0 Abstract Omicron lineages BA.4 and BA.5 drove a fifth wave of COVID-19 cases in South Africa. Here, we use the presence/absence of the S-gene target as a proxy for SARS-CoV-2 variant/lineage for infections diagnosed using the [...]

    Categories: I-CARE Early Covid

    Tags:

  • Reference: Oral nirmatrelvir and severe COVID-19 outcomes during the Omicron surge.

    Published On: September 1, 2022

    Authors: Arbel R, Sagy YW, Hoshen M, Battat E, Lavie G, Sergienko R et al. PMID: 36001529 PMCID: PMC9454652 DOI: 10.1056/NEJMoa2204919 Abstract Background: The oral protease inhibitor nirmatrelvir has shown substantial efficacy in high-risk, unvaccinated patients infected with the B.1.617.2 (delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Data regarding the effectiveness of [...]

    Categories: I-CARE Early Covid

    Tags: COVID-19, nirmatrelvir, Omicron

  • Reference: Rapid initiation of nasal saline irrigation: hospitalizations in COVID-19 patients randomized to alkalinization or povidone-iodine compared to a national dataset.

    Published On: August 25, 2022

    Authors:Baxter AL, Schwartz KR, Johnson RW, Srinivasa AS. PMID:36007135 DOI: 10.1177/01455613221123737 Abstract Objective: To determine whether initiating saline nasal irrigation after COVID-19 diagnosis reduces hospitalization and death in high-risk outpatients compared with observational controls, and if irrigant composition impacts severity. Methods: Participants 55 and older were enrolled within 24 hours of a + PCR COVID-19 [...]

    Categories: I-CARE Early Covid, I-PREVENT

    Tags:

  • Reference: Rapidly increasing serum 25(OD)D boosts immune system, against infections – Sepsis and COVID-19.

    Published On: July 21, 2022

    Authors: Wimalawansa SJ. PMID: 35889955 PMCID: PMC9319502 DOI: 10.3390/nu14142997 Abstract Vitamin D deficiency is a global public health problem, a pandemic that commonly affects the elderly and those with comorbidities such as obesity, diabetes, hypertension, respiratory disorders, recurrent infections, immune deficiency, and malignancies, as well as ethnic minorities living in temperate countries. The same groups [...]

    Categories: I-CARE Early Covid, I-PREVENT, MATH+

    Tags:

  • Reference: Insights from a computational analysis of the SARS-CoV-2 Omicron variant: Host-pathogen interaction, pathogenicity, and possible therapeutics.

    Published On: July 10, 2022

    Authors: Parvez SA, Saha MK, Araf Y, Islam T, Ohtsuki G PMID: 35759231 PMCID: PMC9210926 DOI: 10.1002/iid3.639 Abstract Introduction: Prominently accountable for the upsurge of COVID-19 cases as the world attempts to recover from the previous two waves, Omicron has further threatened the conventional therapeutic approaches. The lack of extensive research regarding Omicron has raised [...]

    Categories: I-CARE Early Covid

    Tags:

  • Reference: What the latest Omicron subvariants mean for the pandemic.

    Published On: June 23, 2022

    Authors: Callaway E doi: https://doi.org/10.1038/d41586-022-01730-y Abstract The lineages’ rise seems to stem from their ability to infect people who were immune to earlier forms of Omicron and other variants. Keywords: vaccines, virology, SARS-CoV2 Source: https://www.nature.com/articles/d41586-022-01730-y Archive: https://archive.is/M7EN7

    Categories: I-CARE Early Covid

    Tags:

  • Reference: Neutralization escape by SARS-CoV-2 omicron subvariants BA.2.12.1, BA.$, and BA.5.

    Published On: June 22, 2022

    Authors: Hachmann NP, Miller J, Collier AY, Ventura JD, Yu J PMID: 35731894 PMCID: PMC9258748 DOI: 10.1056/NEJMc2206576 Abstract In recent months, multiple lineages of the omicron (B.1.1.529) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have emerged,1 with subvariants BA.1 and BA.2 showing substantial escape from neutralizing antibodies.2-5 Subvariant BA.2.12.1 is now the dominant [...]

    Categories: I-CARE Early Covid

    Tags:

  • Reference: D,L-lysine acetylsalicylate + glycine impairs coronavirus replication.

    Published On: June 21, 2022

    Authors: Muller C, Karl N, Ziebuhr J, Pleschka S PMID: 35805887 PMCID: PMC9266999 doi: 10.3390/ijms23136880 Abstract The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing the coronavirus disease-19 (COVID-19) is still challenging healthcare systems and societies worldwide. While vaccines are available, therapeutic strategies are developing and need to be adapted to each patient. Many clinical [...]

    Categories: I-CARE Early Covid

    Tags:

  • Reference: Rapid relapse of symptomatic SARS-CoV-2 infection following early suppression with Nirmatrelvir/Ritonavir.

    Published On: April 26, 2022

    Authors: Gupta K, Strymish J, Stack G, Chamess M DOI: https://doi.org/10.21203/rs.3.rs-1588371/v1 Abstract Initiation of NM/R treatment on Day 0 in a 71-year-old vaccinated and boosted male resulted in rapid resolution of COVID-19 symptoms followed one week later by the development of typical cold symptoms. SARS-CoV-2 viral load fluctuated in parallel with symptoms, with two distinct [...]

    Categories: I-CARE Early Covid

    Tags: COVID-19, nirmatrelvir, SARS-CoV-2

12Next
FLCCC Logo with white letters
Support Us

We are a 100% donor-supported 501(c)(3) non-profit organization. Our work would not be possible without you! Help us expand our reach and share life-saving research.

Give Now
shop
Contact Us
Mailing Address

FLCCC Alliance
2001 L St. NW Suite 500
Washington, DC 20036

Media

[email protected]

Clinical Support

[email protected]

General

[email protected]

Shortcuts
  • About the FLCCC

  • Protocols

  • Providers

  • Physicians

  • Testimonials

  • Latest Updates

  • Newsletter Signup

Follow Us